PARP inhibitors as maintenance treatment for pancreatic cancer patients with germline BRCA mutations

被引：0
|
作者：
Kawecki, Maciej [1 ]
机构：
[1] Maria Sklodowska Curie Inst Oncol, Dept Radiotherapy & Oncol, Warsaw, Poland
来源：
ONCOLOGY IN CLINICAL PRACTICE | 2019年 / 15卷 / 03期
关键词：
D O I：
10.5603/OCP.2019.0023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：190 / 193
页数：4
相关论文
共 50 条
  • [31] PARP inhibitors: shifting the paradigm in the treatment of pancreatic cancer
    Desai, Devashish
    Khandwala, Pushti
    Parsi, Meghana
    Potdar, Rashmika
    MEDICAL ONCOLOGY, 2021, 38 (06)
  • [32] PARP inhibitors and chemotherapy in breast cancer patients with BRCA-1 or BRCA-2 gene mutations: a systematic review
    Arivia, C.
    Sidharta, F.
    Triaswhoro, G. Lintang
    Atmadji, W.
    Sito, W. Winston
    Angelius, C.
    Kurniawan, A.
    Huang, I.
    ANNALS OF ONCOLOGY, 2024, 35 : S1391 - S1391
  • [33] Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients
    Hilmi Özcelik
    Beverly Schmocker
    Nando Di Nicola
    Xiu-Hong Shi
    Bernard Langer
    Malcolm Moore
    Bryce R. Taylor
    Steven A. Narod
    Gerarda Darlington
    Irene L. Andrulis
    Steven Gallinger
    Mark Redston
    Nature Genetics, 1997, 16 : 17 - 18
  • [34] Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients
    Ozcelik, H
    Schmocker, B
    DiNicola, N
    Shi, XH
    Langer, B
    Moore, M
    Taylor, BR
    Narod, SA
    Darlington, G
    Andrulis, IL
    Gallinger, S
    Redston, M
    NATURE GENETICS, 1997, 16 (01) : 17 - 18
  • [35] PARP Inhibitors in Pancreatic Cancer
    Brown, Timothy J.
    Reiss, Kim A.
    CANCER JOURNAL, 2021, 27 (06): : 465 - 475
  • [36] Identification of Germline Genetic Mutations in Patients With Pancreatic Cancer
    Salo-Mullen, Erin E.
    O'Reilly, Eileen M.
    Kelsen, David P.
    Ashraf, Asad M.
    Lowery, Maeve A.
    Yu, Kenneth H.
    Reidy, Diane L.
    Epstein, Andrew S.
    Lincoln, Anne
    Saldia, Amethyst
    Jacobs, Lauren M.
    Rau-Murthy, Rohini
    Zhang, Liying
    Kurtz, Robert C.
    Saltz, Leonard
    Offit, Kenneth
    Robson, Mark E.
    Stadler, Zsofia K.
    CANCER, 2015, 121 (24) : 4382 - 4388
  • [37] Germline mutations in Japanese familial pancreatic cancer patients
    Takai, Erina
    Yachida, Shinichi
    Shimizu, Kyoko
    Furuse, Junji
    Kubo, Emi
    Ohmoto, Akihiro
    Suzuki, Masami
    Hruban, Ralph H.
    Okusaka, Takuji
    Morizane, Chigusa
    Furukawa, Toru
    ONCOTARGET, 2016, 7 (45) : 74227 - 74235
  • [38] Cost-Effectiveness Analysis of Olaparib Maintenance Treatment for Germline BRCA-Mutated Metastatic Pancreatic Cancer
    Li, Na
    Zheng, Huanrui
    Huang, Yanlei
    Zheng, Bin
    Cai, Hongfu
    Liu, Maobai
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [39] Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer
    Xie, Yijun
    Xiao, Di
    Li, Duo
    Peng, Mei
    Peng, Wei
    Duan, Huaxin
    Yang, Xiaoping
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [40] Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancer
    Real, FX
    Malats, N
    Lesca, G
    Porta, M
    Chopin, S
    Lenoir, GM
    Sinilnikova, O
    GUT, 2002, 50 (05) : 653 - 657
12345